baricitinib
Olumiant Approved to Treat Hospitalized Adults With COVID-19
The FDA approved a new indication for baricitinib (Olumiant, Lilly) for the treatment of hospitalized adult ...
MAY 18, 2022
FDA Authorizes Baricitinib Alone as COVID-19 Treatment
The FDA revised the emergency use authorization (EUA) for baricitinib to enable its use alone for the treatment of ...
JULY 29, 2021
Load more